newsfilter
← Latest News
GlobeNewswire·

NRx Pharmaceuticals Reports Positive FDA Office of Generic Drugs Feedback on Preservative-Free Ketamine Program

NRx has received a positive review letter (Discipline Review Letter) addressing Drug Quality requesting only "Minor" administrative changesNRx conducted a meeting with leadership of the FDA Office of Generic Drugs in